Lexeo Therapeutics Completes $153.8 Million Public Offering and Private Placement

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised Lexeo Therapeutics, and Paul Hastings has advised the underwriters.Lexeo Therapeutics, a clinical-stage genetic medicine company focused on pioneering treatments…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here